Moderna (NASDAQ: MRNA), pharmaceutical giant, is on its second stage of coronavirus vaccine. mRNA shares – to date – have risen nearly 160%. The company is one of a handful of biotechnologists working on a …
Moderna (MRNA) Rockets After FDA News. Is MRNA a Buy? Read More »
Moderna (NASDAQ: MRNA), a US biotechnology company, launched an experimental coronavirus vaccine for US government researchers only six weeks after starting work on immunization. The stock is currently up 22%. Initial vaccine vaccination tests could …
Moderna (MRNA) Stock Soars Over 20% on Coronavirus Vaccine Read More »
Get your Free List of 21 Dividend Stock Picks & Market Reports For Advisors & Accredited Investors.
